Education
About Us
Working with TipRanks
Follow Us
Dominic Smethurst Insider Profile
4 Followers
Dominic Smethurst, CMO at Bicycle Therapeutics, holds 70.81K shares in Corbus Pharmaceuticals (Ticker: CRBP), holds 36.70K shares in Bicycle Therapeutics (Ticker: BCYC). Most recently, Dominic Smethurst Sold ― shares of Corbus Pharmaceuticals on Mar 07, 2025 for an estimated value of 43.28K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+22.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dominic Smethurst holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 05, 2023 - Jan 05, 2024
Return:+45.20%
The most profitable trade made by Dominic Smethurst
Dominic Smethurst's Trading History
Bicycle Therapeutics
Jan 05, 2023
CMO
Uninformative Buy
―
$375.43K
Corbus Pharmaceuticals
Mar 07, 2025
CMO
Informative Sell
43.28K
$480.78K
List of latest transactions for each holding click on a transaction to see Dominic Smethurst's performance on stock
You May Also Like
Dominic Smethurst insider profile FAQ
What is the percentage of profitable transactions made by Dominic Smethurst?
The percentage of profitable transactions made by Dominic Smethurst is 50%.
What is the average return per transaction made by Dominic Smethurst?
The average return per transaction made by Dominic Smethurst is 22.60%.
What stocks does Dominic Smethurst hold?
Dominic Smethurst holds: BCYC, CRBP stocks.
What was Dominic Smethurst’s latest transaction?
Dominic Smethurst latest transaction was an Informative Sell of $43.28K.
What was Dominic Smethurst's most profitable transaction?
Dominic Smethurst’s most profitable transaction was an Informative Sell of BCYC stock on January 5, 2023. The return on the trade was 45.20%.
What is Dominic Smethurst's role in Bicycle Therapeutics?
Dominic Smethurst's role in Bicycle Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.